Assessment of Serum Acylated Ghrelin in Children and Adolescents with Chronic Liver Diseases: Relation to Nutritional Status
Table 1
Clinical and laboratory data among cases and controls.
Cases ()
Controls ()
Age (years)
7.55 ± 3.46 (1–16)
7.6 ± 2.50 (1–15.5)
1.24
0.22
Height SDS
−1.75 ± 1.58 (−3.82–0.95)
+0.69 ± 1.7 (0.99–1.84)
5.71
0.03*
BMI (Kg/m2)
14.2 ± 1.06 (12.5–18.71)
20.2 ± 0.91 (14.1–23.9)
8.89
0.0001***
BMI SDS
−1.85 ± 0.21 (−3.15–0.98)
+0.89 ± 0.28 (0–1.54)
6.11
0.0001***
TSFT percentile
16 ± 5.5 (4.15–55.70)
66 ± 6.5 (25.15–78.70)
21.80
0.0001***
SSFT percentile
18 ± 5.5 (6.15–57.70)
65 ± 4.4 (23–77.70)
19.89
0.0001***
Haemoglobin (g/dL)
10.4 ± 1.19 (9–12.5)
13 ± 1.33 (10.5–14.5)
7.11
0.01*
ALT (IU/L)
39.6 ± 13.35 (18–98)
15.65 ± 3.35 (19.5–34.0)
7.22
0.01*
AST (IU/L)
36 ± 10.25 (19–70)
12 ± 2.5 (5.12–32.5)
6.55
0.01*
Total bilirubin (mg/dL)
1.94 ± 0.88 (0.5–5.89)
0.5 ± 0.1 (0.2–1.0)
5.66
0.03*
Albumin (g/dL)
3.05 ± 0.46 (1.89–4.2)
4.88 ± 0.56 (3.82–5.92)
4.89
0.04*
PT (seconds)
14.42 ± 1.64 (12–18.7)
11.5 ± 1.20 (10–12.45)
5.10
0.03*
Ghrelin (pg/mL)
130 ± 46.13 (40–210)
38.4 ± 18.11 (12–62)
15.98
0.0001***
Results are expressed as mean ± SD and range; and , SDS: standard deviation score, BMI: body mass index, TSFT: triceps skin fold thickness, SSFT: subscapular skin fold thickness, ALT: alanine aminotransferase, AST: aspartate aminotransferase, and PT: prothrombin time.
